Clinical trial

Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

NCT02921035

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-06-30

PhaseN/A

Study timeline

Study start (actual)2016-06-30Date precision: day

Registry last updated2022-04-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing Multiple Sclerosis (RMS)unresolved

Interventions

Rebif (Interferon beta-1a)DRUG

Sponsors & collaborators

Merck KGaA, Darmstadt, Germanylead sponsor

Merck Serono Middle East FZ LLCcollaborator

Mapped research locations

BudapestHungary3 CairoEgypt2 SeoulSouth Korea1 WarsawPoland1 SofiaBulgaria1 LodzPoland1 LublinPoland1 GdanskPoland1 KatowicePoland1 RosarioArgentina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02921035 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.